课题基金 / 基金详情

NORTH CENTRAL CANCER TREATMENT GROUP

NORTH CENTRAL CANCER TREATMENT GROUP
中北癌症治疗组
批准号:
6223567
负责人:
MICHAEL J O'CONNELL
金额:
$562.5万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1982
资助国家:
美国
项目状态:
已结题
起止时间:
1982-01-01 至 2005-12-31

项目摘要

项目成果

MICHAEL J O'CONNELL的其他基金

相似基金

相关文献

中文摘要
翻译
北方中心癌症治疗小组(NCCTG)是一个多学科的研究组织,主要由社区医生组成,并与作为其主要研究基地的梅奥诊所癌症中心(NCI指定的综合癌症中心)合作。其广泛和长期的目标是:1)开发和测试癌症治疗的新方法,以提高成年癌症患者的存活率和生活质量;2)为癌症患者提供在其家庭社区进行最先进的临床试验的机会;3)通过转译研究和对临床数据库的分析,促进对癌症生物学的发现,从而促进治疗的改进;4)为癌症预防和症状管理的研究提供平台和基础设施;以及5)为未得到充分服务的人群提供获得NCCTG临床研究方案的机会。NCCTG战略的前提是社区诊所可以进行高质量的癌症治疗研究,社区诊所为新的癌症治疗程序在普通人群中的适用性提供最终的试验场。具体目的是推进胃肠癌、乳腺癌、肺癌、脑肿瘤、恶性血液病患者的治疗,并选择其他成人实体瘤;寻找肿瘤治疗方法,将导致更好的癌症治疗。NCCTG为实现其目标而采用的方法包括试点、II期和III期临床试验;对参与临床试验的患者的组织样本或血液样本进行的实验室相关研究;以及临床和实验室数据库的分析。
英文摘要
The North Center Cancer Treatment Group (NCCTG) is a multi- disciplinary research organization comprised primarily of community physicians in concert with the Mayo Clinic Cancer Center (an NCI- designated Comprehensive Cancer Center) which serves as its primary Research Base. Its broad, long-term objectives are to 1) develop and test new methods of cancer treatment to improve survival and quality of life for adult patients with malignant disease, 2) provide cancer patients access to state-of-the-art clinical trials in their home community, 3) promote discoveries elucidating the biology of cancer through translational research studies And analyses of clinical databases which will lead to improvements in therapy, 4) provide a platform and infrastructure for studies of cancer prevention and symptom management, and 5) provide underserved populations access to NCCTG clinical research protocols. The NCCTG strategy is based on the premises that quality cancer treatment research can be conducted by the community clinic, and that the community clinic provides the ultimate proving ground for applicability of new cancer treatment procedures to the general population. Specific aims are to advance the treatment of patients with gastrointestinal cancer, breast cancer, lung cancer, brain tumors, hematologic malignancies, and select other adult solid tumors; to identify tumor treatment which will lead to better cancer therapy. Methods utilized by the NCCTG to achieve its goals include pilot, phase II, and phase III clinical trials; laboratory correlative studies performed on tissue specimens or blood samples from patients participating in clinical trials,; and analyses of clinical and laboratory databases.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CLINICAL TRIALS PROGRAM
  • 批准号:
    6268791
  • 项目类别:
  • 资助金额:
    $10.07万
  • 财政年份:
    1997
  • 负责人:
    MICHAEL J O'CONNELL
  • 依托单位:
CLINICAL TRIALS PROGRAM
  • 批准号:
    6236194
  • 项目类别:
  • 资助金额:
    $14.62万
  • 财政年份:
    1997
  • 负责人:
    MICHAEL J O'CONNELL
  • 依托单位:
COMMUNITY CLINICAL ONCOLOGY PROGRAM
  • 批准号:
    2089347
  • 项目类别:
  • 资助金额:
    $78.37万
  • 财政年份:
    1983
  • 负责人:
    MICHAEL J O'CONNELL
  • 依托单位:
COMMUNITY CLINICAL ONCOLOGY PROGRAM
  • 批准号:
    2089350
  • 项目类别:
  • 资助金额:
    $2.41万
  • 财政年份:
    1983
  • 负责人:
    MICHAEL J O'CONNELL
  • 依托单位:
海外基金